No Image

Huawei Kevin Hu: Intelligent Cloud-Network Inspires New Growth

October 19, 2021 mtadmin 0

DUBAI, UAE, Oct. 19, 2021 /PRNewswire/ — At the 7th Ultra-Broadband Forum (UBBF 2021), Kevin Hu, President of Huawei’s Data Communication Product Line, introduced four new features of Huawei’s Intelligent Cloud-Network Solution and all-scenario NetEngine series intelligent routers, providing differentiated cloud-network convergence service capabilities and accelerating digital transformation for industries. Digitalization has become a global development trend, […]

No Image

Peng Song, Huawei : exploiter le modèle C.A.F. pour étendre la connectivité et insuffler une nouvelle dynamique de croissance

October 19, 2021 mtadmin 0

DUBAÏ, Émirats arabes unis, le 19 octobre 2021 Le 7e Ultra-Broadband Forum (UBBF 2021) s’est ouvert aujourd’hui à Dubaï. Lors de cet évènement, Peng Song, Président du service Marketing et ventes de solutions de Global Carrier chez Huawei, a prononcé un discours introductif intitulé « Extend Connectivity, Drive Growth » (Étendre la connectivité, stimuler la croissance). Il a défini et élaboré le […]

No Image

Huawei Peng Song: C.A.F Model Is Key to Building Network Competitiveness and Driving Growth

October 19, 2021 mtadmin 0

DUBAI, UAE, Oct. 19, 2021 /PRNewswire/ — The 7th Ultra-Broadband Forum (UBBF 2021) opened today in Dubai. At the event, Peng Song, President of Global Carrier Marketing & Solution Sales at Huawei, delivered a keynote speech titled “Extend Connectivity, Drive Growth”. He defined and elaborated Huawei’s C.A.F (Coverage Architecture Fusion) model. Peng highlighted that “There are […]

No Image

Adagio Therapeutics Announces New In Vitro Data Highlighting Broad and Potent Neutralization of ADG20 Against All Known SARS-CoV-2 Variants

October 19, 2021 mtadmin 0

Data to be presented at the 2021 ISIRV-WHO Virtual Conference WALTHAM, Mass., Oct. 19, 2021 (GLOBE NEWSWIRE) — Adagio Therapeutics, Inc., (Nasdaq: ADGI) a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with pandemic potential, today announced new in vitro data demonstrating retained neutralizing activity of its monoclonal antibody […]